However, 230 patients is not a small number for an NGS study focused only on early lung adenocarcinoma, compared with previous NGS studies.11,27 The CTNNB1 and fusion genes were rare, and the recurrence rate of early lung cancer was low, so the number of patients with recurrence-related specific genes was inevitably small. The gene discussed is CTNNB1; the disease is lung cancer.